Cargando…

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis

Lumbar spinal canal stenosis (LSS) or mechanical compression of dorsal root ganglion (DRG) is one of the causes of low back pain and neuropathic pain (NP). Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator that is produced mainly from lysophosphatidylcholine (LPC) via autotaxin (ATX)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uranbileg, Baasanjav, Ito, Nobuko, Kurano, Makoto, Kano, Kuniyuki, Uchida, Kanji, Sumitani, Masahiko, Aoki, Junken, Yatomi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889906/ https://www.ncbi.nlm.nih.gov/pubmed/33597645 http://dx.doi.org/10.1038/s41598-021-83569-3

Ejemplares similares

Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
por: Uranbileg, Baasanjav, et al.
Publicado: (2019)

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
por: Kurano, Makoto, et al.
Publicado: (2022)

Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study
por: Edamura, Tatsuma, et al.
Publicado: (2022)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022)

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022)

Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
por: Enooku, Kenichiro, et al.
Publicado: (2016)

Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects
por: Yukiura, Hiroshi, et al.
Publicado: (2015)

Lysophospholipids in laboratory medicine
por: YATOMI, Yutaka, et al.
Publicado: (2018)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
por: Sato, Masaya, et al.
Publicado: (2016)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε)
por: Tokuhara, Yasunori, et al.
Publicado: (2015)

Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy
por: Kageyama, Yuko, et al.
Publicado: (2020)

Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma
por: Uranbileg, Baasanjav, et al.
Publicado: (2020)

Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression
por: Takahashi, Chiharu, et al.
Publicado: (2017)

Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021)

The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism
por: Harada, Sayaka, et al.
Publicado: (2023)

Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells
por: Liu, Yang, et al.
Publicado: (2022)

Urine autotaxin levels reflect the disease activity of sarcoidosis
por: Murakami, Koji, et al.
Publicado: (2022)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Involvement of autotaxin in the pathophysiology of elevated intraocular pressure in Posner-Schlossman syndrome
por: Igarashi, Nozomi, et al.
Publicado: (2020)

Analysis of glycero-lysophospholipids in gastric cancerous ascites
por: Emoto, Shigenobu, et al.
Publicado: (2017)

Serum levels of apolipoprotein A-I and E are associated with postoperative delirium: A post hoc analysis
por: Mietani, Kazuhito, et al.
Publicado: (2022)

Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
por: Ishimaru, Kazuhiro, et al.
Publicado: (2019)

Crosstalk between transforming growth factor β-2 and Autotaxin in trabecular meshwork and different subtypes of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2021)

Aqueous autotaxin and TGF-βs are promising diagnostic biomarkers for distinguishing open-angle glaucoma subtypes
por: Igarashi, Nozomi, et al.
Publicado: (2021)

Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
por: Kurano, Makoto, et al.
Publicado: (2022)

Effect of postoperative corticosteroids on surgical outcome and aqueous autotaxin following combined cataract and microhook ab interno trabeculotomy
por: Honjo, Megumi, et al.
Publicado: (2021)

GPR34 in spinal microglia exacerbates neuropathic pain in mice
por: Sayo, Akira, et al.
Publicado: (2019)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
por: Liu, Mengxuan, et al.
Publicado: (2022)

Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022)

Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
por: Kurano, Makoto, et al.
Publicado: (2015)

Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid
por: Omi, Jumpei, et al.
Publicado: (2021)

Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study
por: Tsuchida, Rikuhei, et al.
Publicado: (2023)

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pj1mmptqmr9gbtnvshq22iojho